跳转至内容
Merck
CN

MABF3172

Anti-Sup35p-NM Antibody, clone 4A5

别名:

ERF-3, ERF2, ERF3, Eukaryotic peptide chain release factor GTP-binding subunit, G1 to S phase transition protein 1, Omnipotent suppressor protein 2, PSI no more protein 2, Polypeptide release factor 3, Translation release factor 3

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.43
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
4A5, monoclonal
Application:
ICC, WB
Citations:
-
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

rat

Quality Level

conjugate

unconjugated

antibody form

purified antibody

antibody product type

primary antibodies

clone

4A5, monoclonal

mol wt

calculated mol wt 76.55 kDa, observed mol wt ~45 kDa

purified by

using protein G

species reactivity

yeast

packaging

antibody small pack of 100

technique(s)

immunocytochemistry: suitable, western blot: suitable

isotype

IgG2aκ

epitope sequence

N-terminal half

Protein ID accession no.

UniProt accession no.

storage temp.

2-8°C

target post-translational modification

unmodified

Gene Information

yeast ... SUP35(851752)

General description

Eukaryotic peptide chain release factor GTP-binding subunit (UniProt: P05453; also known as ERF-3, ERF3, ERF2, G1 to S phase transition protein 1, Omnipotent suppressor protein 2, PSI no more protein 2, Polypeptide release factor 3, Translation release factor 3) is encoded by the SUP35 (also known as GST1, PNM2, SAL3, SUF12, SUP2, YD9395.05) gene (Gene ID: 851752) in Saccharomyces cerevisiae (yeast). Sup35 is a GTPase component of the eRF1-eRF3-GTP ternary complex, a complex that mediates translation termination in response to the termination codons UAA, UAG, and UGA. The eRF1-eRF3-GTP complex binds to a stop codon in the ribosomal A-site. The Saccharomyces cerevisiae (yeast) epigenetic element [PSI+] that has multiple structural variants, is a prion of the translation termination factor subunit Sup35p. The yeast Sup35p and the mammalian PrP prion protein share little structural or functional homology except for a repeat region in the amino terminal domain. Sup35 contains three domains: The N-terminal domain (aa 1-123), which is necessary and sufficient for the [PSI+] propagation; the middle domain (M)(aa 124-253) that interacts with the Hsp104 chaperone through the residues 128-148 and is involved in the liquid-liquid phase separation behavior of Sup35 and imparts stability of the prior during mitosis; and the C-terminal domain (aa 254-685) that acts in translation termination. The N-terminal region also contains a prion-forming domain (aa 1-97) that is unstructured in its native soluble form, but forms beta sheets in its amyloid form. Overexpression of the N-domain is shown to increase the frequency of [PSI+] in yeast. Clone 4A5 specifically recognizes the M-domain of Sup35p and is suitable for Western blotting and immunocytochemistry applications. (Ref.: Dergalev, AA., et al. (2019). Int. J. Mol. Sci. 20(11): 2633; Krammer, C., et al. (2009). Proc. Natl. Acad. Sci. USA. 106 (2); 462-467; Krammer, C., et al. (2008). Prion. 2(3); 99-106).

Immunogen

KLH-conjugated linear peptide corresponding to 19 amino acids from the M-domain of SUP35p protein from Saccharomyces cerevisiae (yeast).

Application

Quality Control Testing

Evaluated by Western Blotting in lysate from HEK293 cells transfected with HA-tagged Sup35 NM.

Western Blotting Analysis: A 1:500 dilution of this antibody detected Sup35NM (M Domain) in lysate from HEK293 cells transfected with HA-tagged Sup35NM.

Tested Applications

Immunocytochemistry Analysis: A representative lot detected Sup35/HEFE-ME in Immunocytochemistry applications (Krammer, C., et al. (2009). Proc Natl Acad Sci USA. 106(2):462-7).

Western Blotting Analysis: A representative lot detected Sup35/HEFE-ME in Western Blotting applications (Riemschoss, K., et al. (2019). Life Sci Alliance. 2(4):e201800280).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Biochem/physiol Actions

Clone 4A5 is a rat monoclonal antibody that detects Eukaryotic peptide chain release factor GTP-binding subunit (SUP35p). It targets an epitope within 19 amino acids from the N-terminal half.

Physical form

Purified rat monoclonal antibody IgG2a in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Preparation Note

0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Recommended storage: +2°C to +8°C.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


Still not finding the right product?

试用我们的 产品选型工具 工具缩小选择范围


存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



全球贸易项目编号

货号GTIN
MABF3172-100UG04065271059122
MABF3172-25UG04065271059139